CARBAMAZEPINE OVERDOSE: A PROSPECTIVE STUDY OF SERUM LEVELS AND TOXICITY

References

• Baldessarini R J. Drugs effective in the therapy of the epilepsies. The Pharmacologic Basis of Therapeutics., A G Gilamn, L S Goodman. MacMillan, New York 1980; 457–459
   Google Scholar
• Ellenhorn M J, Barceloux D G. Medical Toxicology. Elsevier, New York 1988; 231–240
   Google Scholar
• Litovitz T L, Schmitz B F, Holm K C. 1988 Annual Report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1989; 7: 495–545
   PubMed Web of Science ®Google Scholar
• Bradbury A J, Todd P J, Bentick B. Dystonia associated with carbamazepine toxicity. Postgrad Med J 1982; 58: 525–526
   PubMed Web of Science ®Google Scholar
• Berry D J, Wiseman H M, Volans G N. . A survey of non-barbiturate anticonvulsant drug reported to the Poisons Information Service (UK). Human Toxicol 1983; 2: 357–360
   PubMedGoogle Scholar
• Degroot G, VanHeijst A NP, Maes R AA. . Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning. J Toxicol Clin Toxicol 1984; 22: 349–362
   PubMedGoogle Scholar
• Denning D W, Matheson L, Bryson S M. et al. Death due to carbamazepine self-poisoning: remedies reviewed. Human Toxicol 1985; 4: 225–260
   Google Scholar
• De Zeeuw R A, Van Der Klein E V, Gimbrere J SF. An unusual case of carbamazepine poisoning with a near-fatal relapse after two days. J Toxicol Clin Toxicol 1979; 14: 263–269
   Google Scholar
• Coutselinis A, Poulos L. An unusual case of carbamazepine poisoning. J Toxicol Clin Toxicol 1980; 16: 385–387
   Google Scholar
• Gary N E, Byra W M, Eisinger R P. Carbamazepine poisoning: treatment by hemoperfusion. Nephron 1981; 27: 202–203
   PubMedGoogle Scholar
• Gooden D J, Phie J L. Bullous skin eruption associated with carbamazepine overdose. Postgrad Med J 1983; 59: 336–337
   PubMed Web of Science ®Google Scholar
• Drenck N E, Risbo A. Carbamazepine poisoning, a suprisingly severe case. Anaeth Intens Care 1980; 8: 203–205
   PubMed Web of Science ®Google Scholar
• Hundt H KL, Aucamp A K, Muller O F. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Human Toxicol 1983; 2: 607–614
   PubMedGoogle Scholar
• Lehrman S N, Bauman M L. Carbamazepine overdose. Am J Dis Child 1981; 135: 768–769
   PubMedGoogle Scholar
• Leslie P J, Hayworth R, Prescott L F. Cardiac complications of carbamazepine intoxication: treatment by haemoperfusion. Brit Med J 1983; 286: 1018
   PubMed Web of Science ®Google Scholar
• Nilsson C, Sterner G, Idval J. Charcoal hemoperfusion for treatment of serious carbamazepine poisoning. Acta Med Scand 1984; 216: 137–140
   PubMed Web of Science ®Google Scholar
• May D C. Acute carbamazepine intoxication: Clinical spectrum and management. S Med J 1984; 77: 24–26
   PubMed Web of Science ®Google Scholar
• O'Neal W, Whitten K M, Baumann R J, Blouin R A, Piecoro J J. Lack of serious toxicity following carbamazepine overdosage. Clin Pharm 1984; 3: 545–547
   PubMedGoogle Scholar
• Patsalos P N, Krishna S, Elyas A A, Lascelles P T. Carbamazepine and carbamazepine-l0,11-epoxide pharmacokinetics in an overdose. Human Toxicol 1987; 6: 241–244
   PubMedGoogle Scholar
• Rockoff S, Baselt R C. Severe carbamazepine poisoning. J Toxicol Clin Toxicol 1981; 18: 935–939
   Google Scholar
• Saloman M. Acute carbamazepine encephalopathy. JAMA 1975; 231: 915
   PubMed Web of Science ®Google Scholar
• Sullivan J P, Rumack B H, Peterson R G. Acute carbamazepine toxicity resulting from overdose. Neurology 1981; 31: 621–624
   PubMed Web of Science ®Google Scholar
• Vree T B, Janssen T J, Hekster Y A, Termond E FS, Van de Dries A CP, Wijnands W JA. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Therapeutic Drugs Monitoring 1986; 8: 297–304
   PubMed Web of Science ®Google Scholar
• Weaver D F, Camfield P, Fraser A. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes. Neurology 1981; 31: 621–624
   PubMedGoogle Scholar
• Fisher R S, Cysyk B. A fatal overdose of carbamazepine: a case report and review of the literature. J Toxicol Clin Toxicol 1988; 26: 477–486
   PubMed Web of Science ®Google Scholar
• Insley-Vuignier B, Woo O F, Becker C E. Fatal carbamazepine overdose with seizure: role of hemoperfusion. Vet Human Tox 1986; 28: 504
   Google Scholar
• Hooper W D, Dubetz D K, Bochner F, et al. Plasma protein binding of carbamazepine. Clin Pharmacol Therapeutics 1975; 17: 433–440
   PubMed Web of Science ®Google Scholar
• Lawless L, DeMonaco H J. Acute carbamazepine toxicity resulting from overdose. Neurology 1982; 32: 328
   PubMed Web of Science ®Google Scholar
• Friis M L, Christiansen J, Hvidberg E F. Brain concentrations of carbamazepine and carbamazepine-l0,11-epoxidein epileptic patients. Europ J Clin Plmrrnacol 1978; 14: 47–51
   PubMedGoogle Scholar
• Kossoy A F, Weir M R. Therapeutic indications in carbamazepine overdose. S Med J 1985; 78: 999–1000
   PubMed Web of Science ®Google Scholar
• Woody R C. Use of serum drug concentration determination in therapeutic and toxic clinical situations. S Med J 1986; 79: 1049–1050
   PubMed Web of Science ®Google Scholar
• Camfield P R, Camfield C S. Serum concentrations of carbamazepine. J Pediatr 1985; 107: 826–827
   PubMed Web of Science ®Google Scholar
• Durelli L, Massazza U, Cavallo R. Carbamazepine toxicity and poisoning incidence, clinical features and management. Med Toxico Adverse Drug Exper 1989; 4: 95–107
   PubMedGoogle Scholar